Press release
Invitation to Nanoform's Q4 and full year 2021 report
The company will hold an online presentation and conference call the same day at
The presentation will be broadcast live as a webcast available at:
https://financialhearings.com/event/13598
Teleconference dial-in numbers:
For further information, please contact:
Director of Investor Relations
hvh@nanoform.com
+46 7686 650 11
About Nanoform
Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform's platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules' performance through its nanoforming technologies and formulation services. Nanoform's capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Nanoform's shares are listed on the Premier-segment of Nasdaq First North Growth Market in
https://news.cision.com/nanoform/r/invitation-to-nanoform-s-q4-and-full-year-2021-report-february-22--2022,c3500720
https://mb.cision.com/Main/18905/3500720/1531368.pdf
(c) 2022 Cision. All rights reserved., source